Compare ALG & ADPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALG | ADPT |
|---|---|---|
| Founded | 1955 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.5B |
| IPO Year | 1993 | 2019 |
| Metric | ALG | ADPT |
|---|---|---|
| Price | $191.25 | $17.64 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 10 |
| Target Price | ★ $225.00 | $16.60 |
| AVG Volume (30 Days) | 111.4K | ★ 2.0M |
| Earning Date | 02-26-2026 | 02-10-2026 |
| Dividend Yield | ★ 0.72% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 9.64 | N/A |
| Revenue | ★ $1,615,388,000.00 | $252,754,000.00 |
| Revenue This Year | $1.26 | $50.86 |
| Revenue Next Year | $5.09 | $0.53 |
| P/E Ratio | $19.57 | ★ N/A |
| Revenue Growth | N/A | ★ 42.57 |
| 52 Week Low | $156.30 | $6.26 |
| 52 Week High | $233.29 | $20.76 |
| Indicator | ALG | ADPT |
|---|---|---|
| Relative Strength Index (RSI) | 66.83 | 56.82 |
| Support Level | $188.19 | $16.55 |
| Resistance Level | $195.17 | $18.14 |
| Average True Range (ATR) | 5.40 | 0.93 |
| MACD | 0.86 | 0.13 |
| Stochastic Oscillator | 86.77 | 75.24 |
Alamo Group Inc is engaged in the design, manufacture, and servicing of high-quality vegetation management and infrastructure maintenance equipment for governmental, industrial and agricultural use. Its products include tractor-mounted and self-propelled mowers, zero-turn mowers, agricultural implements, tree and branch chippers, forestry/wood recycling equipment, street and parking lot sweepers, leaf and debris collection equipment, truck mounted highway attenuator trucks, vacuum trucks, hydro-excavation equipment, telescopic boom excavators, and snow removal equipment. The company's reportable segments are Vegetation Management and Industrial Equipment. It generates a majority of revenue from Vegetation Management. Geographically, it generates the majority of revenue from United States.
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).